Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myeloma

JAAD Case Rep. 2023 Aug 1:40:1-3. doi: 10.1016/j.jdcr.2023.07.024. eCollection 2023 Oct.

Authors

Christopher J Fay¹, Christopher Iriarte^{1

2}, Dorsa Moslehi^{1

2}, Jimmy Lam^{1

2}, Igor Katsyv³, Nicole R LeBoeuf^{1

2}

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts.
² Harvard Medical School, Boston, Massachusetts.
³ Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Keywords: MGUS; NXG; monoclonal gammopathy of undetermined significance; multiple myeloma; necrobiotic xanthogranuloma.

Publication types

Case Reports